
Perfusion chromatography offers improved separation of oligonucleotide biotherapeutics at ultra-high velocities.

Daniel Meston is an application scientist in the Bio Consumables Division at Agilent Technologies, specializing in solutions for the characterization and analysis of biotherapeutics. He supports scientists in developing robust chromatographic methods for complex biomolecules. His expertise is rooted in understanding the fundamental mechanisms governing chromatographic retention and efficiency for large biomolecules, including proteins, peptides, and oligonucleotides. Daniel has extensive experience in two-dimensional liquid chromatography (2D-LC), spanning both method and instrumentation development. His work has contributed to advancing separation science through the development of innovative chromatographic approaches and multidimensional workflows. By combining a strong foundation in separation theory with practical application expertise, Daniel helps address complex analytical challenges and supports improved characterization strategies for next-generation biotherapeutic products.

Perfusion chromatography offers improved separation of oligonucleotide biotherapeutics at ultra-high velocities.

Knowing the tips and tricks of producing quality LC–MS data for peptide analysis can help streamline troubleshooting when problems occur.